Press release - InsightAce Analytic Pvt. Ltd - Needle Tracking System Market: Ensuring Accuracy and Driving Growth in Medical Procedures - published on openPR.com
C4 Therapeutics has an average rating of outperform and price targets ranging from $1 to $84, according to analysts polled by Capital IQ.
Price: 2.84, Change: +0.5, Percent Change: +21.37
.
C4 Therapeutics shares more than doubled amid heavy trading after the company said late Tuesday that clinical data from an ongoing trial of CFT7455 for the potential treatment of multiple myeloma.
C4 Therapeutics surged 59% premarket on Tuesday, following a license and research collaboration agreement with Merck to develop degrader-antibody conjugates.
Icosavax shares soared 47%,.